Walleye Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Walleye Capital's VRTX Position: Q3 2026 in Review
Walleye Capital increased its Vertex Pharmaceuticals (VRTX) stake by 2,726% in Q3 2026, buying an estimated $4.68M and bringing the position to 9,466 shares worth $4.95M. The position accounts for ﹤0.01% of the portfolio, ranked #1902.
Walleye Capital first reported a position in VRTX in Q1 2019 and has held it in 28 quarters since. The position peaked at $19.4M in Q3 2022. 1,782 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Walleye Capital held 9,466 shares of Vertex Pharmaceuticals worth $4.95M as of Q3 2026.
- Walleye Capital bought 9,131 Vertex Pharmaceuticals shares in Q3 2026, an estimated $4.68M.
- Vertex Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #1902 holding.
- Walleye Capital first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
- Walleye Capital's Vertex Pharmaceuticals position peaked at $19.4M in Q3 2022.
- 1,782 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.